Endoscopic treatment of convexity arachnoid cysts.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 23149590)

Published in Childs Nerv Syst on November 14, 2012

Authors

Songbai Gui1, Xuyi Zong, Chuzhong Li, Yazhuo Zhang

Author Affiliations

1: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.

Articles cited by this

Ultrastructure and pathogenesis of intracranial arachnoid cysts. J Neuropathol Exp Neurol (1981) 2.44

Arachnoid cysts associated with subdural hematomas and hygromas: analysis of 16 cases, long-term follow-up, and review of the literature. Neurosurgery (1997) 1.96

Congenital supratentorial arachnoidal and giant cysts in children: a clinical study with arguments for a conservative approach. Childs Nerv Syst (1997) 1.64

Intracranial arachnoid cysts in children. A comparison of the effects of fenestration and shunting. J Neurosurg (1991) 1.28

Endoscopic approach to arachnoid cyst. Childs Nerv Syst (1999) 1.24

How often do chronic extra-cerebral haematomas occur in patients with intracranial arachnoid cysts? J Neurol Neurosurg Psychiatry (2007) 1.22

Endoscopic management of arachnoid cysts: an advancing technique. J Neurosurg (2007) 1.13

Endoscopic management of intra and paraventricular CSF cysts. Childs Nerv Syst (2007) 1.08

Treatment option for arachnoid cysts. Childs Nerv Syst (2009) 1.05

Endoscopic treatment of middle fossa arachnoid cysts: a series of 40 patients treated endoscopically in two centres. Childs Nerv Syst (2009) 1.00

Suprasellar cysts: clinical presentation, surgical indications, and optimal surgical treatment. BMC Neurol (2011) 0.91

Assessment of endoscopic treatment for middle cranial fossa arachnoid cysts. Childs Nerv Syst (2011) 0.90

Spontaneous disappearance of a suprasellar arachnoid cyst: case report and review of the literature. Childs Nerv Syst (2006) 0.89

Endoscopic cystoventriculostomy for treatment of paraxial arachnoid cysts. J Neurosurg (2009) 0.88

Neuroendoscopic techniques in the treatment of arachnoid cysts in children and comparison with other operative methods. Childs Nerv Syst (2006) 0.84

Double-endoscopic approach for management of convexity arachnoid cyst: case report. Surg Neurol (2004) 0.82

Treatment of symptomatic intracranial arachnoid cysts by stereotactic cyst-ventricular shunting. Stereotact Funct Neurosurg (1999) 0.78

Articles by these authors

Analysis of intracellular nucleoside triphosphate levels in normal and tumor cell lines by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 1.20

Endoscopic transsphenoidal treatment of pituitary adenomas. Neurol Res (2008) 0.93

Low levels of PRB3 mRNA are associated with dopamine-agonist resistance and tumor recurrence in prolactinomas. J Neurooncol (2013) 0.83

The effectiveness of neuroendoscopic versus non-neuroendoscopic procedures in the treatment of lateral ventricular cysts: a retrospective medical record review study. BMC Neurol (2013) 0.83

Overexpression of the Notch3 receptor and its ligand Jagged1 in human clinically non-functioning pituitary adenomas. Oncol Lett (2013) 0.82

Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice. Colloids Surf B Biointerfaces (2011) 0.81

TLR9 expression is associated with prognosis in patients with glioblastoma multiforme. J Clin Neurosci (2011) 0.80

Protective effects of taurine against closed head injury in rats. J Neurotrauma (2015) 0.80

Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models. J Neurooncol (2014) 0.79

Reversion of multidrug resistance in human glioma by RNA interference. Neurol Res (2008) 0.79

Extrapontine myelinolysis of osmotic demyelination syndrome in a case of postoperative suprasellar arachnoid cyst. Case Rep Med (2012) 0.79

Reversal of multidrug resistance by magnetic chitosan-Fe₃O₄ nanoparticle-encapsulated MDR₁ siRNA in glioblastoma cell line. Neurol Res (2013) 0.78

Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior. Pituitary (2015) 0.78

Anatomic study of the anterior skull base via an endoscopic transnasal approach. Clin Neurol Neurosurg (2011) 0.78

Nestin expression and proliferation of ependymal cells in adult rat spinal cord after injury. Chin Med J (Engl) (2002) 0.77

Analysis of differential gene expression by fiber-optic BeadArray and pathway in prolactinomas. Endocrine (2010) 0.77

Analysis of differential gene expression in plurihormonal pituitary adenomas using bead-based fiber-optic arrays. J Neurooncol (2012) 0.77

Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas. J Neurooncol (2014) 0.77

Analysis of differential gene expression by bead-based fiber-optic array in growth-hormone-secreting pituitary adenomas. Exp Ther Med (2010) 0.77

Effects of an estrogen receptor antagonist on proliferation, prolactin secretion and growth factor expression in the MMQ pituitary prolactinoma cell line. J Clin Neurosci (2011) 0.76

Melatonin modulates the effects of diethylstilbestrol (DES) on the anterior pituitary of the female Wistar rat. Folia Histochem Cytobiol (2010) 0.76

C6 glioma cells retrovirally engineered to express IL-18 and Fas exert FasL-dependent cytotoxicity against glioma formation. Biochem Biophys Res Commun (2004) 0.75

Effects of estrogen receptor antagonist on biological behavior and expression of growth factors in the prolactinoma MMQ cell line. J Neurooncol (2010) 0.75

Study on miRNAs' expression for the invasion of pituitary adenomas. Turk Neurosurg (2017) 0.75

Effects of fulvestrant, an estrogen receptor antagonist, on MMQ cells and its mechanism. Neuro Endocrinol Lett (2009) 0.75

Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma. Pituitary (2015) 0.75

Establishment of multidrug-resistance cell line C(6)/adr and reversal of drug-resistance. Chin Med J (Engl) (2002) 0.75

Differentiation of rat embryonic neural stem cells promoted by co-cultured Schwann cells. Chin Med J (Engl) (2003) 0.75

The Wnt/β-catenin signaling pathway is involved in the antitumor effect of fulvestrant on rat prolactinoma MMQ cells. Tumour Biol (2014) 0.75

Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas. J Clin Neurosci (2013) 0.75

Etiology of Pituitary Tumors: A Case Control Study. Turk Neurosurg (2016) 0.75

Analysis of differential gene expression using fiber-optic bead array and pathway analyses in pituitary adenomas. J Clin Neurosci (2011) 0.75